The Rising Trend of THC Inflation in the Cannabis Industry

A trend stirring up the cannabis industry is THC inflation, a phenomenon captured in the wake of Organigram's recent statements following their disappointing quarterly earnings. Organigram, a well-renown cannabis company, saw a significant 20% drop in its stock due to weaker than expected earnings. In light of these results, Organigram's CEO, Bina Goldenberg, commented that THC inflation was a significant factor in the company's underwhelming performance. 

What is THC Inflation?

THC inflation refers to the increasing potency of cannabis in the market. Notably, Goldenberg revealed that 50% of cannabis flower sales in Q3 were labeled as containing 26% or more THC — a surprisingly high percentage. Moreover, she disclosed that the number of SKUs with THC levels above 30% had increased tenfold compared to last year. 

In particular, the 28-gram cannabis flower category—equivalent to an entire ounce—was significantly impacted by this inflation. This is perhaps unsurprising, considering that regular consumers are likely to develop higher tolerances and, thus, seek products with higher potency. 

THC Inflation - A Genuine Issue or Misrepresentation? 

Goldenberg raised concerns about producers claiming their flower contains THC levels ranging from 28% to 32%, stating that such claims are unrealistic. She suggests that manipulating the results of lab testing could be the cause of these inflated figures, pointing to past examples of labs publishing higher potency levels via their testing and ultimately facing penalties for doing so. 

This creates a disadvantageous landscape for all stakeholders—cultivators, labs, businesses, and consumers. On the one hand, cultivators have to shop their products around to different labs, seeking the best potency readings to compete in a demanding marketplace. On the other hand, consumers may not get an accurate understanding of the product they consume due to skewed testing results and do not get a fair representation of the THC levels they are handling, posing potential risks.

Comparing THC Inflation with Alcohol

The trend of THC inflation is somewhat similar to the alcohol industry's issue with ABV (Alcohol By Volume) inflation. Especially in beers where craft variants like double IPAs are gaining popularity. These craft beers have higher alcohol content, and while they may be more expensive due to higher production costs, consumers perceive them as a better "bang for their buck" due to the heightened intoxication experienced. 

However, in comparison to cannabis products, higher potency products and larger package sizes offer a lower price per gram or price per milligram, making them more attractive to consumers. it may also be why this generation leans more toward cannabis compared to alcohol, given that the impacts of alcohol abuse are significantly more recognizable and harmful.

Attempted Remedies by Organigram

To tackle THC inflation, Organigram reported several strategies that they plan to implement, including reducing flower prices, boosting their cannabis potency in a transparent and legitimate manner, innovating new products, and advocating for stricter regulations with Health Canada.

However, it seems that they have a long way to go. While they wish to appeal to a broad consumer base beyond just high THC products, it seems that the market demands otherwise. With higher potency products taking precedence in the market, innovations might have to be steered toward meeting these current trends instead of trying to create a new market niche.

In conclusion, THC inflation presents a complicated problem that could reshape the cannabis industry considerably. Emerging concerns about the legitimacy of THC levels necessitate urgent attention and resolution. The challenges faced by Organigram may only be the beginning of a wider industry issue if not timely addressed.